ArticleF1000 medicine reports2012
Helicobacter pylori: Eradication or Preservation.
Article in F1000 medicine reports, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers, 2 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
25 citing papers in PubMed, 2 syntheses or guidelines pooled it.
- Levofloxacin/amoxicillin-based schemes vs quadruple therapy for Helicobacter pylori eradication in second-line.World journal of gastroenterology · 2012Pooled it
- Is Helicobacter pylori infection associated with asthma risk? A meta-analysis based on 770 cases and 785 controls.International journal of medical sciences · 2012Pooled it
- Role of TRPV4 in the Diagnosis and Treatment ofBioMed research international · 2022Trial
- Validation of a Gastric-Juice-Analysis-Based Approach toDiagnostics (Basel, Switzerland) · 2026Article
- Co-Occurrence ofBiomedicines · 2025Review
- Association betweenBMJ open gastroenterology · 2024Article
- Flavonoids and related privileged scaffolds as potential urease inhibitors: a review.RSC advances · 2023Review
- Consumption of a Gelatin Supplemented with the Probiotic StrainFoods (Basel, Switzerland) · 2022Article
- Nutrient Deficiency Promotes the Entry ofBiology · 2021Article
- Helicobacter pylori Related Diseases and Osteoporotic Fractures (Narrative Review).Journal of clinical medicine · 2020Review
- Gastrointestinal Disorders and Metabolic Syndrome: Dysbiosis as a Key Link and Common Bioactive Dietary Components Useful for their Treatment.International journal of molecular sciences · 2020Review
- Chilean Rhubarb,Frontiers in pharmacology · 2020Article
- Helicobacter pylori infection in children: an overview of diagnostic methods.European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology · 2019Review
- Helicobacter pylori, transmission routes and recurrence of infection: state of the art.Acta bio-medica : Atenei Parmensis · 2018Review
- MUC1 and MUC5AC Acting onEvidence-based complementary and alternative medicine : eCAM · 2018Article
- Association between cagA, vacAi, and dupA genes of Helicobacter pylori and gastroduodenal pathologies in Chilean patients.Folia microbiologica · 2017Article
- The Mechanisms UnderlyingTanaffos · 2017Review
- [Kyoto global consensus report for treatment of Helicobacter pylori and its implications for China].Zhejiang da xue xue bao. Yi xue ban = Journal of Zhejiang University. Medical sciences · 2016Article
- Dietary, non-microbial intervention to prevent Helicobacter pylori-associated gastric diseases.Annals of translational medicine · 2015Review
- Connexin 32 and 43 promoter methylation in Helicobacter pylori-associated gastric tumorigenesis.World journal of gastroenterology · 2014Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
Abstract
Helicobacter pylori infects about 50% of the world's population and inevitably results in the development of gastritis. Of those infected, about 10% develop peptic ulcer disease and roughly 1% develop gastric cancer. Conversely, some take the view that H. pylori infection provides some protection against gastro-esophageal reflux disease and possibly asthma. This review aims to explore the case for and against eradication of the bacterium using a "test and treat" approach amongst the general population.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.